Geneo Grissom

Esperanza, Auberge Resorts Collection Debuts Revitalized Spa Rooted in Mexican Healing Traditions

Retrieved on: 
Wednesday, December 13, 2023

LOS CABOS, Mexico, Dec. 13, 2023 /PRNewswire-PRWeb/ -- Esperanza, Auberge Resorts Collection, Los Cabos' most iconic luxury resort, today reopens its Forbes 5 Star award-winning spa as a new holistic and cultural wellness experience with transformative treatments, a refreshed look and feel and immersive wellbeing journeys. Drawing inspiration from the philosophy and practice of the medicine wheel and indigenous Mexican healing traditions, the spa experience debuts spiritually guided spa offerings to promote holistic restoration in a newly elevated environment.

Key Points: 
  • Drawing inspiration from the philosophy and practice of the medicine wheel and indigenous Mexican healing traditions, the spa experience debuts spiritually guided spa offerings to promote holistic restoration in a newly elevated environment.
  • "We are thrilled to re-introduce the spa at Esperanza, Auberge Resorts Collection with a new ancestral healing philosophy, inspired by Baja California's distinct locale and Mexico's rich history and culture," said Marc Rodriguez, General Manager, Esperanza, Auberge Resorts Collection.
  • "The Spa at Esperanza will continue to deliver impressive results and further celebrate the soul of Esperanza that guests and owners have come to know and love.
  • Enhanced treatments, contemporary menu offerings and state-of-the-art technology, including the latest in Geneo facial technology, promote a personalized approach to well-being rooted in traditional therapies."

FONTAINEBLEAU LAS VEGAS UNVEILS TRANSFORMATIVE TREATMENT MENU FOR LAPIS SPA & WELLNESS

Retrieved on: 
Tuesday, December 5, 2023

LAS VEGAS, Dec. 5, 2023 /PRNewswire/ -- Fontainebleau Las Vegas, the luxury resort and casino brought to life by Fontainebleau Development, is revealing the menu for Lapis Spa & Wellness, offering an exceptional suite of personalized treatments, premium therapies, and cutting-edge wellness rituals to boost wellbeing and inspire productivity. Reservations are now open for individual and group bookings at the 55,000-square-foot, two-level spa, opening December 14, 2023 as the ultimate destination for rejuvenation, immediately following Fontainebleau Las Vegas' grand opening one day earlier.

Key Points: 
  • LAS VEGAS, Dec. 5, 2023 /PRNewswire/ -- Fontainebleau Las Vegas , the luxury resort and casino brought to life by Fontainebleau Development, is revealing the menu for Lapis Spa & Wellness, offering an exceptional suite of personalized treatments, premium therapies, and cutting-edge wellness rituals to boost wellbeing and inspire productivity.
  • "Lapis Spa & Wellness is the convergence of age-old rejuvenation techniques and contemporary healing technologies," explains Fontainebleau Las Vegas Director of Spa and Wellness Jennifer Lynn.
  • Designed by Milan-based Lissoni & Partners, Lapis Spa & Wellness is located on the second level of the Fontainebleau Las Vegas tower, adjacent to the resort's 14,000-square-foot fitness center.
  • Unique Lapis Spa & Wellness amenities include:
    Dr. Barbara Sturm Facials – Lapis Spa & Wellness has partnered with aesthetics expert, orthopedics specialist, and anti-inflammatory pioneer Dr. Barbara Sturm to offer a transformative array of facial therapies.

Geneos Therapeutics Closes its Series A3 Financing With Investment of $5 Million

Retrieved on: 
Thursday, September 28, 2023

PLYMOUTH MEETING, Pa., Sept. 27, 2023 /PRNewswire/ -- Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines (PTCV), today announced that it has completed its Series A3 financing round with an additional investment of $5 million, totaling $10 million. This investment adds Shanghai Healthcare Capital (SHC) to Geneos' investor syndicate. Dr. Jing Bao will join as a board observer, bringing extensive expertise in the pharmaceutical industry and with global clinical trials.

Key Points: 
  • PLYMOUTH MEETING, Pa., Sept. 27, 2023 /PRNewswire/ -- Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines (PTCV), today announced that it has completed its Series A3 financing round with an additional investment of $5 million, totaling $10 million.
  • This investment adds Shanghai Healthcare Capital (SHC) to Geneos' investor syndicate.
  • Dr. Jing Bao will join as a board observer, bringing extensive expertise in the pharmaceutical industry and with global clinical trials.
  • "We are pleased to add SHC to our investor syndicate and Dr. Bao to our team.

Geneos Therapeutics Announces Eight of 34 Patients to Achieve Complete Response, Complete Molecular Response, or, Secondary Resectability in Ongoing Clinical Trial of Personalized Therapeutic Cancer Vaccination in Second Line Advanced Liver Cancer

Retrieved on: 
Tuesday, August 22, 2023

PLYMOUTH MEETING, Pa., Aug. 22, 2023 /PRNewswire/ -- Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines (PTCV), today announced updated data from GT-30, an ongoing single-arm open-label multi-center Phase 1b/2a study in second-line advanced hepatocellular carcinoma (HCC). Previously, Geneos reported three patients to have achieved a complete response (CR) and a fourth patient to be cancer-free, whose liver and lung lesions shrank to become fully responsive to surgery and radiation (secondary resectability).

Key Points: 
  • Geneos reports today that four additional patients have achieved a complete molecular response (CMR) by ultrasensitive, third-generation, circulating tumor DNA (ctDNA) analysis.
  • By RECIST1.1, three of these four patients are durable partial responses (PR) and one a durable stable disease (SD).
  • By either RECIST1.1 or by ctDNA response, 11 of 32 evaluable have achieved either a complete response, partial response, or complete molecular response.
  • Cancer vaccines based on our DNA vaccine platform are showing complete responses in patients with late-stage, advanced cancer.

Geneos Therapeutics Nominated for 2023 Prix Galien USA Startup Award

Retrieved on: 
Friday, July 28, 2023

PLYMOUTH MEETING, Pa., July 28, 2023 /PRNewswire/ -- Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines (PTCV), today announced that it has been nominated for the Prix Galien Startup Award for 2023. The Galien Foundation is the premier global institution dedicated to honoring innovators in life sciences and oversees the Prix Galien, an international awards program dedicated to progress through innovative medicines development.

Key Points: 
  • PLYMOUTH MEETING, Pa., July 28, 2023 /PRNewswire/ -- Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines (PTCV), today announced that it has been nominated for the Prix Galien Startup Award for 2023.
  • The Galien Foundation today announced the 2023 Prix Galien USA Award nominees for Best Startup, Best Digital Health Solution, Best Medical Technology, and Incubators, Accelerators and Equity.
  • The 2023 Prix Galien USA Awards Committee is composed of nine renowned leaders from the biomedical industry and academia, responsible for evaluating nominees.
  • "We are honored to be nominated for the 2023 Prix Galien Startup Award and are delighted to be in such excellent company of the other nominees," stated Niranjan Sardesai, Ph.D., president and chief executive officer of Geneos Therapeutics.

INTRODUCING GLO2FACIAL™ BY GENEO - THE GO-TO TREATMENT FOR REBALANCED BEAUTY

Retrieved on: 
Thursday, March 23, 2023

NEWPORT BEACH, Calif., March 23, 2023 /PRNewswire/ -- Big news bubbled up today as Geneo reintroduced its patented Oxfoliation™ treatment as the Glo2Facial™ – launching its new brand and sharing its vision to become the treatment of choice by consumers and professionals worldwide.

Key Points: 
  • The Glo2Facial™ by Geneo works with everything and is for everyone.
  • He is also the founder and board member of OrangeTwist, a leading chain of treatment shops for body, face and skin.
  • Carnell recognized an opportunity to partner with Lumenis to build Geneo into a global brand.
  • For more information and to find a local treatment provider, please visit www.glo2facial.com

Geneos Announces Expansion of Leadership Team

Retrieved on: 
Wednesday, October 12, 2022

PLYMOUTH MEETING, Pa., Oct. 12, 2022 /PRNewswire/ -- Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines (PTCV), today announced that the company has expanded its leadership team and has elected Dr. Laurent Humeau to the company's board of directors.

Key Points: 
  • He brings device related scientific, analytical, manufacturing, and regulatory expertise to the Geneos Board as Geneos prepares for later stage clinical development of its PTCV programs.
  • Geneos has licensed the CELLECTRA devices from Inovio exclusively for delivery of its personalized therapeutic cancer vaccine products.
  • With her expanded leadership role, Ms. Peters now leads all facets of Geneos' clinical and business operations, providing oversight to clinical trials and implementing operational strategy and structure.
  • Geneos has an experienced management team with a track record of success in building immunotherapy-based companies.

Grit Studio™ Expands Team of Award-Winning Creatives and Grows Client Portfolio with Several National Consumer Brands

Retrieved on: 
Thursday, September 8, 2022

WASHINGTON, Sept. 8, 2022 /PRNewswire/ -- Grit Studio™ ("Grit"), a content-first digital marketing studio, announces the appointment of Justyna Wilson as Vice President of Strategy + Accounts and Molli Mayeron as Director of Content + Production, expanding the agency's West Coast presence to Los Angeles and San Francisco. The firm also grew its client portfolio with the addition of three national consumer brands.

Key Points: 
  • The firm also grew its client portfolio with the addition of three national consumer brands.
  • "Justyna and Molli are seasoned marketing professionals with deep expertise in digital marketing strategy, content production, and client services," says Erin Fabio, CEO of Grit Studio.
  • "We're excited to welcome them to the team and look forward to seeing how they level up our client content."
  • Grit Studio ("Grit") is a content-first digital marketing studio that empowers premium beauty, wellness + community brands through creative innovation + data-driven results.

Registration Now Open for Questex’s International Esthetics, Cosmetics & Spa Conference (IECSC) Florida

Retrieved on: 
Thursday, July 28, 2022

NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- Questex’s International Esthetics, Cosmetics & Spa Conference (IECSC) Florida, the most influential gathering of spa and wellness professionals in the Southeast, today announces registration for the event is open. IECSC Florida will be held at the Palm Beach Convention Center, October 9-10, 2022. Register here.

Key Points: 
  • Event Takes Place October 9-10 in West Palm Beach, Florida
    NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- Questex s International Esthetics, Cosmetics & Spa Conference (IECSC) Florida, the most influential gathering of spa and wellness professionals in the Southeast, today announces registration for the event is open.
  • In addition, two nail classes will be part of the conference Integrating Nails into Your Spa Environment and Waterless Spa Pedicures - each presented by Jamie Schrabeck , PhD.
  • In addition, IECSC Florida will host over 200 industry suppliers of the top brands in the skincare and wellness industry.
  • IECSC Florida takes place October 9-10, 2022 at the Palm Beach Convention Center in West Palm Beach, Florida.

Markacy Becomes Agency of Record for Lumenis U.S. Beauty

Retrieved on: 
Wednesday, March 23, 2022

Markacy , a digital strategy and marketing firm headquartered in New York City, became the Agency of Record (AoR) for the U.S. Beauty Division of Lumenis , the worlds largest energy-based medical device company for aesthetic and ophthalmic applications.

Key Points: 
  • Markacy , a digital strategy and marketing firm headquartered in New York City, became the Agency of Record (AoR) for the U.S. Beauty Division of Lumenis , the worlds largest energy-based medical device company for aesthetic and ophthalmic applications.
  • Moreover, technology is having an increasingly important role on the consumer perception and expectations of skincare, said Chris Jones, Managing Partner and Co-Founder of Markacy.
  • Mary Alice Greco, Director of Marketing and Growth Strategy for Lumenis U.S. Beauty added: Markacy appreciates Geneos ambition to be the go-to skincare technology for medical spas and dermatologists.
  • Markacy is a digital strategy firm helping brands launch, grow and scale, by developing and executing cross-channel strategies.